These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


267 related items for PubMed ID: 8627667

  • 1. Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras.
    Kolman JL, Taylor N, Gradoville L, Countryman J, Miller G.
    J Virol; 1996 Mar; 70(3):1493-504. PubMed ID: 8627667
    [Abstract] [Full Text] [Related]

  • 2. Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency.
    Francis AL, Gradoville L, Miller G.
    J Virol; 1997 Apr; 71(4):3054-61. PubMed ID: 9060666
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Latency of Epstein-Barr virus is disrupted by gain-of-function mutant cellular AP-1 proteins that preferentially bind methylated DNA.
    Yu KP, Heston L, Park R, Ding Z, Wang'ondu R, Delecluse HJ, Miller G.
    Proc Natl Acad Sci U S A; 2013 May 14; 110(20):8176-81. PubMed ID: 23625009
    [Abstract] [Full Text] [Related]

  • 5. Mutant Cellular AP-1 Proteins Promote Expression of a Subset of Epstein-Barr Virus Late Genes in the Absence of Lytic Viral DNA Replication.
    Lyons DE, Yu KP, Vander Heiden JA, Heston L, Dittmer DP, El-Guindy A, Miller G.
    J Virol; 2018 Oct 01; 92(19):. PubMed ID: 30021895
    [Abstract] [Full Text] [Related]

  • 6. The Epstein-Barr virus ZEBRA protein activates transcription from the early lytic F promoter by binding to a promoter-proximal AP-1-like site.
    Zetterberg H, Jansson A, Rymo L, Chen F, Karlsson A, Klein G, Brodin B.
    J Gen Virol; 2002 Aug 01; 83(Pt 8):2007-2014. PubMed ID: 12124465
    [Abstract] [Full Text] [Related]

  • 7. Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator.
    Francis A, Ragoczy T, Gradoville L, Heston L, El-Guindy A, Endo Y, Miller G.
    J Virol; 1999 Jun 01; 73(6):4543-51. PubMed ID: 10233912
    [Abstract] [Full Text] [Related]

  • 8. Restoration of the Epstein-Barr virus ZEBRA protein's capacity to disrupt latency by the addition of heterologous activation regions.
    Baumann R, Warren G, Askovic S.
    Virology; 1995 Aug 01; 211(1):64-72. PubMed ID: 7645237
    [Abstract] [Full Text] [Related]

  • 9. Serine-173 of the Epstein-Barr virus ZEBRA protein is required for DNA binding and is a target for casein kinase II phosphorylation.
    Kolman JL, Taylor N, Marshak DR, Miller G.
    Proc Natl Acad Sci U S A; 1993 Nov 01; 90(21):10115-9. PubMed ID: 8234266
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.
    Sato H, Takeshita H, Furukawa M, Seiki M.
    J Virol; 1992 Aug 01; 66(8):4732-6. PubMed ID: 1321269
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F, Sergeant A, Corbo L.
    J Gen Virol; 1996 Mar 01; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [Abstract] [Full Text] [Related]

  • 12. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
    Gradoville L, Kwa D, El-Guindy A, Miller G.
    J Virol; 2002 Jun 01; 76(11):5612-26. PubMed ID: 11991990
    [Abstract] [Full Text] [Related]

  • 13. Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6.
    Flamand L, Menezes J.
    J Virol; 1996 Mar 01; 70(3):1784-91. PubMed ID: 8627701
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c-fos.
    Flemington E, Speck SH.
    J Virol; 1990 Sep 01; 64(9):4549-52. PubMed ID: 2166830
    [Abstract] [Full Text] [Related]

  • 15. Transcriptional synergy by the Epstein-Barr virus transactivator ZEBRA.
    Carey M, Kolman J, Katz DA, Gradoville L, Barberis L, Miller G.
    J Virol; 1992 Aug 01; 66(8):4803-13. PubMed ID: 1321270
    [Abstract] [Full Text] [Related]

  • 16. Phosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta.
    El-Guindy AS, Miller G.
    J Virol; 2004 Jul 01; 78(14):7634-44. PubMed ID: 15220438
    [Abstract] [Full Text] [Related]

  • 17. Structural basis of DNA methylation-dependent site selectivity of the Epstein-Barr virus lytic switch protein ZEBRA/Zta/BZLF1.
    Bernaudat F, Gustems M, Günther J, Oliva MF, Buschle A, Göbel C, Pagniez P, Lupo J, Signor L, Müller CW, Morand P, Sattler M, Hammerschmidt W, Petosa C.
    Nucleic Acids Res; 2022 Jan 11; 50(1):490-511. PubMed ID: 34893887
    [Abstract] [Full Text] [Related]

  • 18. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
    Wu FY, Wang SE, Chen H, Wang L, Hayward SD, Hayward GS.
    J Virol; 2004 May 11; 78(9):4847-65. PubMed ID: 15078966
    [Abstract] [Full Text] [Related]

  • 19. The Epstein-Barr virus Zta transactivator: a member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif.
    Chang YN, Dong DL, Hayward GS, Hayward SD.
    J Virol; 1990 Jul 11; 64(7):3358-69. PubMed ID: 2161945
    [Abstract] [Full Text] [Related]

  • 20. The position of the ZEBRA activation domain does not influence its biological activity.
    Asković S, Taylor W, Baumann R.
    Virus Res; 1998 Oct 11; 57(2):125-38. PubMed ID: 9870581
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.